ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Endometrial Cancer

Prostate Cancer trials near Jacksonville, FL, USA:

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Jacksonville, Florida, United States and 53 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + carboplatin + cabazitaxel

Phase 2

Xencor
Xencor

Jacksonville, Florida, United States and 25 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Active, not recruiting
Prostate Cancer
Device: Vanquish System
Francis Medical

Jacksonville, Florida, United States and 25 other locations

Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate...

Enrolling
Prostate Cancer
Drug: piflufolastat (18F)
Drug: Flotufolastat (18F)

Phase 4

Blue Earth Diagnostics

Jacksonville, Florida, United States and 8 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Jacksonville, Florida, United States and 388 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Jacksonville, Florida, United States and 235 other locations

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Enrolling
Prostatic Neoplasms
Prostate Cancer
Drug: 64Cu-SAR-bisPSMA

Phase 3

Clarity Pharmaceuticals

Jacksonville, Florida, United States and 22 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Jacksonville, Florida, United States and 302 other locations

prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...

Active, not recruiting
Hormone-resistant Prostate Cancer
Stage IV Prostate Cancer
Drug: prednisone
Drug: abiraterone

Phase 3

Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology

Jacksonville, Florida, United States and 538 other locations

Locations recently updated

vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to ...

Enrolling
Oligometastatic Prostate Cancer (OMPC)
Drug: AAA617

Phase 3

Novartis
Novartis

Jacksonville, Florida, United States and 116 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems